RSS Feed
Ambac Faces Do-or-Die in the New Year
The insurer has challenges on all fronts -- the possibility of a delisting, Wisconsin regulatory woes. The biggest is simply staying alive.
09:21AM 12/21/09
Drugmakers Win With Democrats' Help
Pfizer, Merck, GlaxoSmithKline and other pharmaceutical companies got some surprising support from Democratic senators in the defeat of a drug-importation bill.
05:30AM 12/18/09
Prudential Gets Less Money From Venture
Prudential said it will receive $4.5 billion to exit a joint venture with Wells Fargo, half a billion dollars less than originally expected.
11:53AM 12/16/09
Long-Term Care Provision to Boost Insurers
In the health-care reform debate, long-term care needs have been overlooked. If that provision survives the bill, insurers will stand to gain.
05:00AM 12/16/09
Insurance Stocks Worthy of Stocking Stuffers
They sell for less than $5 a share, and their price-to-book values are embarrassingly low. They're cheap insurance stocks that may pay off -- if they survive 2010.
04:30AM 12/15/09
Insurance Stocks That Split the Difference
Not too risky or too conservative, these three insurers are a good value and stand to benefit as the stock market rebounds.
06:22AM 12/14/09
Glaxo, Wyeth Cut Costs With Trial Software
DecisionView, a San Francisco-based startup, helps big pharma companies increase the success of clinical trials for blockbuster drugs.
05:00AM 12/11/09
Insurance Stocks for the Conservative Investor
ACE, American Financial Group and two other stocks give investors a measure of safety with room for growth.
07:45AM 12/10/09
Health-Care Reform Clears Hurdle
Democrats and Republicans are closer than they've ever been, having worked out key compromises.
09:50AM 12/09/09
Insurance Stocks Are Ready to Rally
A confluence of events means insurers' shares are attractive now. The rebounding economy will likely be the catalyst for a broad increase in stock prices.
05:00AM 12/09/09
Connect with TheStreet